SCHEMBL402234

SCHEMBL402234

COC(=O)c1cc(OC)c(O)c(C(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.50
SLC22A12 Q96S37 1/20 0.49
LMNA P02545 4/20 0.49
KDM4E B2RXH2 3/20 0.49
GAA P10253 3/20 0.49
POLB P06746 1/20 0.49
NFKB1 P19838 1/20 0.49
XDH P47989 1/20 0.49
GFER P55789 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
FUT7 Q11130 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
MAPT P10636 3/20 0.47
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA7 P43166 2/20 0.47
CA9 Q16790 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1458272 0.85 CA12 (0.68) SLC22A12LMNACA12CA1CA2
SCHEMBL17535700 0.85 NOTUM (0.49) NOTUMSLC22A12LMNAKDM4EGAA
SCHEMBL10323908 0.85 HSD17B2 (0.55) SLC22A12LMNAKDM4EGAAPOLB
Syringate SCHEMBL159392 0.82 CA12 (0.67) LMNAKDM4EGAAPOLBNFKB1
SCHEMBL400754 0.82 NOTUM (0.51) NOTUMLMNAKDM4EGAAPOLB
SCHEMBL753404 0.81 CFTR (0.50) NOTUMLMNAKDM4EGAAPOLB
SCHEMBL31573511 0.81 NOTUM (0.65) NOTUMLMNAKDM4EGAAPOLB
SCHEMBL10322343 0.81 NOTUM (0.50) NOTUMSLC22A12LMNAKDM4EGAA
SCHEMBL399582 0.81 NOTUM (0.65) NOTUMLMNAKDM4EGAAPOLB
SCHEMBL30152983 0.81 CFTR (0.50) NOTUMLMNAKDM4EGAAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA NOTUM 34/4885SLC22A12 1307/4885LMNA 2858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.